Genervon Biopharmaceuticals COO Dorothy Ko tells Proactive Investors the company is gearing up for the PhysChem Forum in Basel, Switzerland, on April 17.
Ko says there has been a lack of methodology to test peptide drugs, however, scientific consultant Dr. Klara Volke will be presenting at the forum how she developed a new HPLC testing method on behalf of Genervon.
Meet 360 Blockchain Inc and Alterola Biotech, Inc at our event,New York, 18 April 2018.Register here >>